Cognitive Behavioral Therapy for Fear of Cancer Recurrence
Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene
Recruiting
N/A
Interventional Study
Breast Cancer Susceptibility Gene (BRCA1) Mutation
BRCA2 Mutation
Fear of Cancer Recurrence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 250 (estimated)
- Sponsor
- CHU de Quebec-Universite Laval · Other
Who this trial is looking for
This trial is looking for women who have a BRCA1/2 gene mutation and fear of their cancer coming back. Participants will take part in weekly online therapy sessions for eleven weeks and fill out questionnaires before and after the program.
Are You a Good Fit for This Trial?
You may be able to join if
- I have completed treatment for breast or ovarian cancer
- I have a BRCA1/2 pathogenic mutation
- I have a high level of fear of cancer recurrence
- I am at least 18 years old
- I can read and understand French
You may not be able to join if
- I have distant metastatic cancer
- I have a BRCA1/2 'VUS' mutation
- I have a cognitive disorder
- I have a severe psychological disorder
- I have participated in the original FCR group therapy
- I am taking psychotropic medication and my dosage has not been stable for at least one month
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine whether an adapted version of a current cognitive-behavioural group therapy (CBT) protocol for cancer survivors to the specific needs of women who are carriers of the BRCA1/2 genetic mutation will reduce their levels of fear of cancer recurrence. The main questions this study aims to answer are:
* Will the women who have received the adapted CBT be …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1\) Have completed primary treatment for breast or ovarian cancer (i.e., surgery, chemotherapy, and radiotherapy).
* 2\) Be known to carry a BRCA1/2 pathogenic mutation.
* 3\) Have a clinical level of fear of cancer recurrence as defined by a score of 13 or more on the Fear of…
Contacts